Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace

After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study. Source: BioSpace

Spark won approval on Dec. 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65. Source: BioSpace

Biotech and pharma execs Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx. Source: BioSpace

The company struck the cash-and-share deals to boost its presence in Europe. Source: BioSpace

Here are five possible acquisition targets to keep an eye on. Source: BioSpace

Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace

Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year. Source: BioSpace

The latest funding round gives XtalPi $20M in the bank, which the company said makes it "one of the top-funded AI-powered biotechs." Source: BioSpace

This acquisition strategy is part of its two-pronged approach to growth, along with internal R&D. Source: BioSpace